Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 3—March 2023
Dispatch

Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016–2022

Deus LukoyeComments to Author , Gail Gustavson, Proscovia M. Namuwenge, Simon Muchuro, Estella Birabwa, Seyoum Dejene, Julius Ssempiira, Julius N. Kalamya, Steven Baveewo, Odile Ferroussier-Davis, Lisa A. Mills, Emilio Dirlikov, Lisa J. Nelson, and Stavia Turyahabwe
Author affiliations: US Centers for Disease Control and Prevention, Kampala, Uganda (D. Lukoye, G. Gustavson, J. Ssempiira, J.N. Kalamya, S. Baveewo, L.A. Mills, E. Dirlikov, L.J. Nelson); Uganda Ministry of Health, Kampala (P.M. Namuwenge, S. Muchuro, S. Turyahabwe); US Department of Defense, Kampala (E. Birabwa); US Agency for International Development, Kampala (S. Dejene); US Centers for Disease Control and Prevention, Atlanta, Georgia, USA (O. Ferroussier-Davis)

Main Article

Table 2

Tuberculosis notification rates per 100,000 persons living with HIV during semiannual periods, in study of tuberculosis preventive therapy among persons living with HIV, Uganda, October 2016–March 2022*

Semiannual periods Overall Patient age
Patient sex
<15 y >15 y M F
2016 Oct–2017 Mar†
881.1 (7,850/890,938)
NA
NA

NA
NA
2017 Apr–2017 Sep‡
523.4 (5,198/993,070)
465.6 (290/62,279)
331.2 (3,083/930,791)

642.0 (2,106/328,026)
201.0 (1,267/630,451)
2017 Oct–2018 Mar†
860.1 (8,866/1,030,756)
NA
NA

NA
NA
2018 Apr–2018 Sep‡
1,015.3 (11,186/1,101,716)
1,633.7 (1,035/63,353)
294.1 (3,054/1,038,363)

547.9 (2,128/388,410)
274.9 (1,961/713,306)
2018 Oct–2019 Mar
1,028.3 (11,284/1,097,366)
1,553.2 (929/59,812)
998.0 (10,355/1,037,554)

1,694.1 (6,528/385,331)
667.9 (4,756/712,035)
2019 Apr–2019 Sep
1,094.4 (12,566/1,148,258)
1,607.6 (985/61,273)
1,065.4 (11,581/1,086,985)

1,774.4 (7,195/405,491)
723.1 (5,371/742,767)
2019 Oct–2020 Mar
918.9 (11,037/1,201,166)
1,182.6 (730/61,731)
904.6 (10,307/1,139,435)

1,489.6 (6,336/425,358)
605.9 (4,701/775,808)
2020 Apr–2020 Sep
710.2 (8,650/1,218,006)
756.6 (462/61,062)
707.7 (8,188/1,156,944)

1,148.3 (4,956/431,584)
469.7 (3,694/786,422)
2020 Oct–2021 Mar
866.8 (10,747/1,239,829)
1,144.3 (678/59,249)
854.1 (10,083/1,180,580)

1,356.2 (5,921/436,577)
602.6 (4,840/803,252)
2021 Apr–2021 Sep
908.8 (11,511/1,266,588)
1,175.1 (703/59,925)
895.6 (10,808/1,206,763)

1,388.7 (6,185/445,390)
648.6 (5,326/821,198)
2021 Oct–2022 Mar 972.5 (12,483/1,283,662) 1,416.5 (813/57,396) 951.7 (11,670/1,226,266) 1,504.8 (6,788/451,092) 684.0 (5,695/832,570)

*Values are no./100,000 population (actual number of notifications among PLHIV/total PLHIV population). Tuberculosis notification rate is defined as the number of registered new and relapsed TB cases with documented HIV-positive status during the reporting period divided by the total number of PLHIV currently receiving antiretroviral treatment at PEPFAR-supported sites in Uganda. NA, not applicable; PEPFAR, US President’s Emergency Plan for AIDS Relief. †Total number of tuberculosis cases disaggregated by age and sex were not available. ‡Disaggregated totals for age groups and sex do not equal the overall totals in periods 2 and 4 because of synchronization issues between DATIM (Uganda DATIM version 1.31 MER 2.5, updated January 4, 2021; https://ug.datim4u.org) and the national reporting system; only the sites in which disaggregated totals were consistent with the national reporting system were included.

Main Article

Page created: January 13, 2023
Page updated: February 20, 2023
Page reviewed: February 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external